BiVictriX Therapeutics is an emerging biotechnology company applying a novel approach to develop next-generation cancer therapies using insights derived from frontline clinical experience.


BiVictriX is dedicated to applying a novel approach in developing safer and effective cancer therapies, by revolutionizing cancer therapy and making curative treatments available to all; By delivering a broad pipeline of proprietary, first-in-class Bi-Cygni® therapeutics to enable potentially higher dosing and more aggressive tumor eradication in patients, without causing harmful side effects.



Status Active
Website https://www.bivictrix.com/
Category Biotech
Modality Small Molecule
Therapautics Area
Headquaters Cheshire, UK
Investment Portfolio Fund Investment